LEADER 01183nam2-2200361---450 
001 990003691900203316
005 20231212094618.0
010   $a978-0-12-391858-1
035   $a000369190
035   $aUSA01000369190
035   $a(ALEPH)000369190USA01
035   $a000369190
100   $a20120926d2012----km-y0itay50------ba
101   $aeng
102   $aUS
105   $a||||||||001yy
200 1 $aNanomedicine$einfectious diseases, immunotherapy, diagnostics, antifibrotics, toxicology and gene medicine$fedited by Nejat Düzgüne?
210   $aAmsterdam [etc.]$cElsevier$d2012
215   $aLIV, 408 p., [6] carte di tav.$cill.$d24 cm
225 2 $aMethods in enzymology$v509
410  0$1001990002876030203316$12001$aMethods in enzymology$v509
606 0 $aMedicina$xImpiego [delle] Nanotecnologie
676   $a610.28
702  1$aDÜZGÜNES,$bNejat
801  0$aIT$bsalbc$gISBD
912   $a990003691900203316
951   $a572.7 MET 509$b5647 Farm.$c572.7$d00058612
959   $aBK
969   $aFAR
979   $aFIORELLA$b90$c20120926$lUSA01$h1455
979   $aFIORELLA$b90$c20120926$lUSA01$h1458
996   $aNanomedicine$91142294
997   $aUNISA